A stable cell line with a homozygous knockout of human TXNDC9 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human GYS1 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human ACAT2 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human PPARG using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human EGF using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human PPM1A using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human PHKG2 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human TPD52 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human ESRP2 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human IVNS1ABP using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human SLC5A2 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human E2F4 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human TIGIT using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human RNF10 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human ADH5 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human NFE2L2 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human HMGB2 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human OCIAD1 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human PRSS23 using CRISPR/Cas9.
A stable cell line with a homozygous knockout of human MAP3K8 using CRISPR/Cas9.